MiNK Therapeutics (INKT) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.8
-0.56
-0.31
-0.07

Details

Expected EPS
-0.800667
Actual EPS
-0.5
Surprise EPS
0.3
Surprise Percent
+37.55%

Description

MiNK Therapeutics (INKT) has reported earnings of -0.5 per share for Q4 2024.

0 Comments

Share your thoughts